ТРАДИЦИОННЫЕ И СОВРЕМЕННЫЕ РАСТВОРИМЫЕ ПРЕБИОТИКИ ПРИРОДНОГО ПРОИСХОЖДЕНИЯ: Публикация 2. Моносахариды, дисахариды, сахарные спирты

T.L. Kiseleva; M.A. Kiseleva; E.V. Khlebnikov

doi:10.54296/18186173_2024_4_19

Authors

T.L. Kiseleva Scientific & Research Centre of Non-profit Organization «Professional Association of Naturotherapists» (Moscow, Russia)
M.A. Kiseleva Scientific & Research Centre of Non-profit Organization «Professional Association of Naturotherapists» (Moscow, Russia)
E.V. Khlebnikov Botanica .group LLC (Moscow, Russia)

DOI:

https://doi.org/10.54296/18186173_2024_4_19

Keywords:

prebiotics, natural prebiotics, soluble prebiotics, monosaccharides, disaccharides, carbohydrate prebiotics, carbohydrate-based prebiotics, sugar alcohols, gut microbiota

Abstract

This study follows our publication devoted to the analysis of existing ideas about the conceptual apparatus and terminology, classification, mechanisms of action and safety of biologically active compounds (BAC) with pro- and prebiotic action, as well as the functions of prebiotics in the body. Our research focuses on the analysis and systematization of modern scientific concepts of monosaccharides, disaccharides and sugar alcohols as carbohydrate prebiotics, as well as an assessment of the possibility and feasibility of their use for the development of drinks with prebiotic properties based on the experience of traditional medicine.
We have analyzed, systematized and generalized traditional and modern concepts of soluble carbohydrate-based biologically active substances with prebiotic properties - monosaccharides, disaccharides and sugar alcohols. We found that the most promising soluble carbohydrate prebiotics include mono- and disaccharides such as tagatose, mannose, arabinose, lactulose and lactobionic acid, as well as some sugar alcohols (lactitol, sorbitol)
The identified BAC may be promising micronutrients for the creation of natural, effective (biologically available) and safe drinks with prebiotic properties.

Author Biography

T.L. Kiseleva, Scientific & Research Centre of Non-profit Organization «Professional Association of Naturotherapists» (Moscow, Russia)

Доктор фармацевтических наук, профессор, директор НИЦ, Президент НО «Профессиональная организация натуротерапевтов»

References

Исследование пребиотической активности гидролизатов маннана в условиях in vitro / Е.П. Анохина, О.С. Корнеева, П.В. Шуваев, И.В. Черемушкина // Вестник ВГУИТ. – 2013. – №4. – С.219–222.

Аполихина, И.А. Гиперактивный мочевой пузырь / И.А. Аполихина, А.С. Саидова // Акушерство и гинекология. – 2019. – S 3/1. – С.15–18.

Ахмедова, В.Р. Разработка технологии кисломолочного мороженого с пребиотическими компонентами: автореф. дис. канд. тех. наук. / В.Р. Ахмедова. – Ставрополь, 2015.

Брацихина М.А. Совершенствование технологии функциональных кисломолочных продуктов с лактулозой: автореф. дис. канд. тех. наук. / М.А. Брацихина. – Ставрополь, 2013.

Воскобойникова, И.В. Лактитол (Экспортал®) – эффективное и безопасное слабительное / И.В. Воскобойникова, В.К. Колхир, О.Н. Минушкин // Эффективная фармакотерапия в гастроэнтерологии. – 2009. – №2. – С.14–16.

Систематический анализ исследований лактитола / О.А. Громова, И.Ю. Торшин, В.А. Максимов [и др.] ЭиКГ. – 2019. – №2(162). – С.131–142.

Громова, О.А. Систематический анализ исследований по D-маннозе и перспективы ее применения при рецидивирующих инфекциях мочеполовых путей у женщин репродуктивного возраста / О.А. Громова, И.Ю. Торшин, Н.К. Тетруашвили // Акушерство Гинекология Репродукция. – 2019. – Т.13(2). – С.119–131.

Возрастная динамика продукции короткоцепочечных жирных кислот кишечной микробиотой у пациентов, не имеющих гастроэнтерологических заболеваний / А.М. Затевалов, Е.П. Селькова, Н.В. Гудова, А.С. Оганесян // Альманах клинической медицины. – 2018. – Т.46, №2. – С.109–117.

Киселева, М.А. Традиционные и современные растворимые пребиотики природного происхождения: Публикация 1. Про- и пребиотики в традиционной медицине и современной концепции питания / М.А. Киселева, Т.Л. Киселева, Е. Хлебников // Традиционная медицина. – 2024. – №3(75). – С.17–50.

Корнеева, О.С. Пребиотические свойства маннозы и ее влияние на специфическую резистентность / О.С. Корнеева, А.С. Глущенко, И.В. Черемушкина // Журнал микробиологии, эпидемиологии и иммунобиологии. – 2012. – №5. – С.51–57.

Кретович, В.Л. Биохимия растений / В.Л. Кретович. – М.: Высшая школа, 1986. – 503 с.

Курмангулов, А.А. Функциональная активность микробиоты кишечника при метаболическом синдроме / А.А. Курмангулов, Е.Ф. Дороднева, Д.Н. Исакова // Ожирение и метаболизм. – 2016. – Т.13, №1. – С.16–19.

Лактитол (Lactitol) // Справочник лекарственных средств ВИДАЛЬ. – Электронный ресурс. – Доступ: https://www.vidal.ru/drugs/molecule/1875. – Дата обращения 02.10.2024.

Лактобионовая кислота // Merck Index, 11th Edition, 5219.

Лактулоза (Lactulosum) // Регистр лекарственных средств России (РЛС). – Электронный ресурс. – Доступ: https://www.rlsnet.ru/active-substance/laktuloza-395#:~:text=Лактулоза%20—%20дисахарид%2C%20состоящий%20из,кальция%2C%20способствует%20выведению%20ионов%20аммония https://www.vidal.ru/drugs/molecule/1875. – Дата обращения 14.09.2024 г.

Маркеры дисбиоза (арабиноза, арабинитол) в разовой порции мочи // Гемохелп. – Электронный ресурс. Доступ: https://gemohelp.ru/id/3773. – Дата обращения 23.12.2024

Методические рекомендации MP 2.3.1.0253-21 «Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации». – Утв. Федеральной службой по надзору в сфере защиты прав потребителей и благополучия человека 22 июля 2021 г. – Введены взамен MP 2.3.1.2432-08.

Мурзин, И.И. Российский рынок пребиотиков: бизнес пищевых ингредиентов, 2011 / И.И. Мурзин. – Электронный ресурс. – Доступ: http://bfi-online.ru/ana2011/index.html?msg=2226. – Дата обращения: 09.10.16.

Потехин, В. Арабиноза, свойства, получение и применение / В. Потехин // Вторая индустриализация России: Химические соединения и вещества. – 2020, 25 сентября. – Электронный ресурс. – Доступ: https://втораяиндустриализация.рф/arabinoza-svoystva-poluchenie-i-primenenie/#primenenie-arabinozy. – Дата обращения 24.12.2024.

Примерный перечень основных лекарственных средств ВОЗ (22-й перечень, апрель 2021 г.). – Электронный ресурс. – Доступ: https://syntheticdrugs.unodc.org/uploads/syntheticdrugs/res/library/access_html/WHO_Model_List_of_Essential_Medicines_RU.pdf. – Дата обращения 13.10.2024.

Радиф, З.Х. Разработка биотехнологии маннозы и маннозосодержащих гидролизатов из растительного сырья и исследование их биологических функций / З.Х. Радиф // Дисс. канд. техн. наук. – Воронеж, 2018. – 116 с.

Рамноза // Большая российская энциклопедия. – Электронный ресурс. – Доступ: https://bigenc.ru/c/ramnoza-4aae94. – Дата обращения 12.12.2024 г.

Рябцева, С.А. Лактулоза в кисломолочных продуктах: новые разработки / С.А. Рябцева // Переработка молока. – 2012. – №10. – С.56–58.

Лактоза и ее производные / Б.М. Синельников, А.Г. Храмцов, И.А. Евдокимов [и др.]. – СПб.: Профессия, 2007. – 786 с.

Ситкин, С.И. Метаболический дисбиоз кишечника и его биомаркеры / С.И. Ситкин, Е.И. Ткаченко, Т.Я. Вахитов // Экспериментальная и клиническая гастроэнтерология. – 2015. – №12(124). – С.6–29.

Сорбитол (Sorbitolum) // Регистр лекарственных средств России. – Электронный ресурс. – Доступ: https://www.rlsnet.ru/active-substance/sorbitol-1770?ysclid=m53ztpgun948201306. – Дата обращения 28.12.2024 г.

Биологически активный гетерогликозид для коррекции патологических состояний центральной нервной системы / C.В. Стовбун, А.А. Литвин, П.В. Якимук, В.И. Сергиенко // Патент 2335289 РФ, МПК A61K 31/715, A61P 25/00; заявитель и патентообладатель ООО «Группа «Новые Технологии». – № 2006117376/15; заявл. 22.05.2006.; опубл. 10.12.2007, Бюл. № 34.

Сычева, Е.Г. Коррекция эстроген-дефицитных состояний у женщин с урогенитальными расстройствами / Е.Г. Сычева, И.А. Аполихина // Акушерство и гинекология. – 2015. – №4. – С.75–79.

Свойства D-маннозы: противовоспалительный и противоопухолевый эффекты / И.Ю. Торшин, И.А. Аполихина, А.Н. Громов, О.А. Громова // Экспериментальная и клиническая урология. – 2020. – №2. – С.164–170.

Хемомикробиомный анализ синергизма D-маннозы и D-фруктозы в сравнении с другими метабиотиками / И.Ю. Торшин, А.Н. Галустян, М.И. Иванова [и др.] // Эффективная фармакотерапия. Урология и нефрология. – 2020. – Т.16, №20. – С.22–31.

Хемомикробиомный анализ Лактитола / И.Ю. Торшин, О.А. Громова, И.Н. Захарова, В.А. Максимов // Экспериментальная и клиническая гастроэнтерология. – 2019. – Вып.164 (№ 4). – С.111–121.

Ферментативное получение D-тагатозы. Патент RU 2 749 811 C1. - Автор Вихелецкий Дэниел Джозеф, Патентообладатель БОНАМОУЗ, ИНК. (US), начало действия 2016.09.30. Публ. 17.06.2001 г. – Электронный ресурс. Доступ: https://yandex.ru/patents/doc/RU2749811C1_20210617. – Дата обращения 23.09.024 г.

Храмцов, А.Г. Технологический прорыв аграрно-пищевых инноваций молочного дела на примере универсального сельхозсырья. Лактобионовая кислота / А.Г. Храмцов // Аграрно-пищевые инновации. – 2019. – №1(5). – 14–23.

Пребиотики как функциональные пищевые ингредиенты: терминология, критерии выбора и сравнительной оценки, классификация / А.Г. Храмцов, С.А. Рябцева, Р.О. Будкевич [и др.] // Вопр. питания. – 2018. – Т.87, №1. – С.5–17.

Чепурной, И.П. Питание и здоровье человека / И.П. Чепурной. – М.: Медицина, 2003. – 208 с.

Чепурной, И.П. Способ лечения сахарного диабета / И.П. Чепурной, К.Э. Больбат // Патент 2097041 РФ, МПК A61K 31/70; заявитель и патентообладатель Чепурной И.П. – №94042023/14; заявл. 22.11.1994.; опубл. 27.11.1997.

Чепурной, И.П. Способ коррекции углеводного состава пищевых продуктов общего и специального назначения / И.П. Чепурной, С.М. Кунижев // Патент РФ 2096974, МПК A23L 1/29; заявитель и патентообладатель Чепурной И.П. – №95111145/13; заявл. 28.06.1995.; опубл. 27.11.1997.

Чепурной, И.П. Способ получения моносахаров и их смесей / И.П. Чепурной, А.И. Марченко // Патент 2090618 Российская Федерация, МПК 6С13К13/00; заявитель и патентообладатель Чепурной И.П. – №95118198/13; заявл. 26.10.1995; опубл. 20.09.1997.

Оптимизация ферментативного гидролиза трудногидролизуемых маннанов и исследование пребиотических свойств маннозы / И.В. Черемушкина, А.С. Глущенко, Е.П. Анохина [и др.] // Биотехнология. – 2010. – №5 – С.56–61.

Щербухин, В.Д.. Способ получения д-маннозы из семян растения рода гледичия / В.Д. Щербухин, Н.М. Местечкина // Патент 2065499 РФ, C13K13/00; заявитель и патентообладатель Институт биохимии им. А.Н. Баха РАН. – № 94024334/13; заявл. 29.06.1994.

Agyeman, V. 10 Best Prebiotic Foods to Eat to Support Gut Health / V. Agyeman // Diet & Nutrition / Published: Mar 22, 2023. – Электронный ресурс. – Доступ: https://www.goodhousekeeping.com/health/diet-nutrition/g43067442/best-prebiotic-foods/. – Дата обращения 04.10.2024 г.

Ait-Aissa, A. Lactulose: production and use in functional food, medical and pharmaceutical applications. Practical and critical review / A. Ait-Aissa, M. Aider // Int. J. Food Sci. Technol. – 2014. – Vol.49. – P.1245–1253.

Alternative sweeteners. O’Brien Nabors L, editor. 4th ed. Boca Raton: CRC Press; 2012. [DOI] [Google Scholar]

Direct utilization of mannose for mammalian glycoprotein biosynthesis / G. Alton, M. Hasilik, R. Niehues [et al.] // Glycobiology. – 1998. – Vol.8, Issue 3. – P.285–295, https://doi.org/10.1093/glycob/8.3.285

Andersen, J.R. The Effects of L-arabinose on Intestinal Sucrase Activity in Man / J.R. Andersen / Clinical Trial NCT00302302 // ICH GCP -US Clinical Trials Registry. – 2014, February 25. – Электронный ресурс. – Доступ: https://ichgcp.net/clinical-trials-registry/NCT00302302. – Дата обращения 24.12.2024 г.

Transcriptional analysis of prebiotic uptake and catabolism by Lactobacillus acidophilus NCFM / J.M. Andersen, R. Barrangou, M.A. Hachem [et al.] // PLoS One. – 2012 (Epub Sep 19). – №7(9): e44409.

Human macrophages differentiated in the presence of vitamin D3 restrict dengue virus infection and innate responses by downregulating mannose receptor expression / J.F. Arboleda Alzate, I.A. Rodenhuis-Zybert, J.C. Hern?ndez [et al.] // PLoS. Negl. Trop. Dis. – 2017. – № 11(10): e0005904.

Awuchi, C.G. Sugar alcoholes: chemistry, production, health concerns and nutritional importance of mannitol, sorbitol, xylitol and erythritol / C.G. Awuchi // Int. J. Adv. Acad. Res. – 2017. – Vol.3. – Р.31–66.

Diarrhea in diabetics: the role of sorbitol / M.S. Badiga, N.K. Jain, C. Casanova, C.S. Pitchumoni // J. Am. Coll. Nutr. – 1990 Dec. – Vol.9(6). – Р.578–82.

Ballongue, J. Effects of lactulose and lactitol on colonic microflora and enzymatic activity / J. Ballongue, C. Schumann, P. Quignon // Scand. J. Gastroenterol. Suppl. 1997. – Vol.32, suppl. 22. – Р.41–44.

Inulin supplementation reduces systolic blood pressure in women with breast cancer undergoing neoadjuvant chemotherapy / Y. Becerril-Alarc?n, S. Campos-G?mez, J.J. Valdez-Andrade [et al.] // Cardiovasc. Ther. – 2019. – Article 5707150.

Belitz, H.-D. Food chemistry. 4th ed. / H.-D. Belitz, W. Grosch, P. Schieberle. – Berlin, Heidelberg: Springer, 2009. – 1114 р.

Bell, L.N. Tagatose stability in milk and diet lemonade / L.N. Bell, K.J. Luecke // Journal of Food Science. – 2012. – Vol. 77(1). – Р.H36–H39.

The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism / G. den Besten, K. van Eunen, A.K. Groen [et al.] // J. Lipid Res. – 2013. – Vol. 54. – Р. 2325–2340.

Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol / M. Bjorklund, A.C. Ouwehand, S.D. Forssten [et al.] // Age (Dordr). – 2012 Aug. – №34(4). – Р.987–999.

Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: Results of a meta-analysis / P. Blanc, J.P. Daures, J.M. Rouillon [et al.] // Hepatology. – 1992. – Vol.15. – Р.222–228.

Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study / E. Boets, S.V. Gomand, L. Deroover [et al.] // The Journal of Physiology. – 2017. – Vol.595(2). – Р.541–555.

Brown, M.R. The amino-acid and sugar composition of 16 species of microalgae used in mariculture / M.R. Brown // Journal of Experimental Marine Biology and Ecology. – 1991. – Vol.145. – Р.79–99.

Lactitol in treatment of chronic hepatic encephalopathy / C. Camm?, F. Fiorello, F. Tin? [et al.] // Digest. Dis. Sci. – 1993. – Vol. 38. – Р.916–922.

Microbial regulation of organismal energy homeostasis / P.D. Cani, M. van Hul, C. Lefort [et al.] // Nature metabolism. – 2019. – Vol.1(1). – Р.34–46.

Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis / C. Chen, L. Li, Z. Wu [et al.] // J. Infect. – 2007 Jan. – №54(1). – Р.98–102.

Mannose-binding lectin in chronic hepatitis B virus infection / W.P. Chong, Y.F. To, W.K. Ip [et al.] // Hepatology. – 2005. – Vol.42(5). – Р.1037–1045.

Chukwuma, C.I. Sorbitol increases muscle glucose uptake ex vivo and inhibits intestinal glucose absorption ex vivo and in normal and type 2 diabetic rats / C.I. Chukwuma, S. Islam // Appl. Physiol. Nutr. Metabol. – 2017. – Vol.42. – Р.377–383.

Recognition of peptidoglycan from the microbiota by nod1 enhances systemic innate immunity / T.B. Clarke, K.M. Davis, E.S. Lysenko [et al.] // Nat. Med. – 2010. – Vol.16. – Р.228–231.

Sorbitol malabsorption in normal volunteers and in patients with coeliac disease / G.R. Corazza, A. Strocchi, R. Rossi [et al.] // Gut. – 1988 Jan. – Vol.29(1). – Р.44–48.

Origins and evolution of the Western diet: health implications for the 21st century / L. Cordain, S.B. Eaton, A. Sebastian [et al.] // Am. J. Clin. Nutr. – 2005 Feb. – Vol.81(2). – Р.341–354.

Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications / D. Davani-Davari, M. Negahdaripour, I. Karimzadeh [et al.] // Foods. – 2019 Mar. – Vol. 8(3). – Article 92.

D-Mannose // National Center for Biotechnology Information // PubChem Compound Summary for CID 18950, D-Mannose. – Электронный ресурс. – Доступ: https://pubchem.ncbi.nlm.nih.gov/compound/D-Mannose. - Дата обращения 22.11.2024 г.

D-mannose: a promising support for acute urinary tract infections in women. A pilot study / L. Domenici, M. Monti, C. Bracchi [et al.] // Eur. Rev. Med. Pharmacol. Sci. – 2016. – Vol.20. – №13. – P.2920–2925.

Role of the microbiome in human development / M.G. Dominguez-Bello, F. Godoy-Vitorino, R. Knight [et al.] // Gut. – 2019. – Vol.68(6). – Р.1108–1114.

Donner, T.W. Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol / T.W. Donner, L.S. Magder, K. Zarbalian // Nutrition Research. – 2010. – Vol.30(12). – Р.801–806.

D-tagatose, a novel hexose: Acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes / T.W. Donner, J.F. Wilber, D. Ostrowski // Diabetes, Obesity and Metabolism. – 1999. – Vol.1(5). – Р.285–291.

D-Tagatose // National Center for Biotechnology Information (NCBI). – Электронный ресурс. – Доступ: https://pubchem.ncbi.nlm.nih.gov/compound/D-Tagatose#section=Biologic-Description. – Дата обращения 24.09.2024 г.

D-Rhamnose // National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 5460029, D-Rhamnose. – Электронный ресурс. – Доступ: https://pubchem.ncbi.nlm.nih.gov/compound/D-Rhamnose. – Дата обращения 24.09.2024 г.

Lactulose in the treatment of chronic portal-systemic encephalopathy: A double-blind clinical trial / S. Elkington, M. Floch, H. Conn // N. Engl. J. Med. – 1969. – Vol.281. – Р.408–412.

Ellis, W.F. Sugar Alcohols XXII. Metabolism and toxicity studies with mannitol and sorbitol in man and animals / W.F. Ellis, J.C. Krantz // J. Biol. Chem. – 1941. – Vol. 141. – Р.147–54.

Effects of three low-doses of D-tagatose on glycemic control over six months / M. Ensor, J. Williams, R. Smith [et al.] // Journal of Endocrinology, Diabetes & Obesity. – 2014. – Vol.2. – Article 1057(4).

European Food Safety Authority. Call for technical and toxicological data on sweeteners authorised as food additives in the EU. – 2017. [Accessed 19 October 2020]. – Электронный ресурс. – Доступ: https://www.efsa.europa.eu/en/data/call/170621.

Mannose-binding lectin mediated complement pathway in autoimmune neurological disorders / M. Farrokhi, M. Dabirzadeh, N. Dastravan [et al.] // Iran. J. Allergy. Asthma. Immunol. – 2016. – Vol.15(3). – Р.251–256.

The role of mannose binding lectin on fever episodes in pediatric oncology patients / F. Fekete, B. Fadgyas, ?. Papp [et al.] // Pathol Oncol Res. – 2016. – Vol.22. – №1. – P.139–143.

Mannose is an insulin-regulated metabolite reflecting whole-body insulin sensitivity in man / E. Ferrannini, M. Bokarewa, P. Brembeck [et al.] // Metabolism. – 2020. – Vol.102. – Article 153974.

Hepatic encephalopathy / D. Festi, G. Marasco, F. Ravaioli, A. Colecchia // Recenti Prog. Med. – 2016 Jul. – Vol.107(7). – Р.378–385.

Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology / M. Finney, J. Smullen, H.A. Foster [et al.] // Eur. J. Nutr. – 2007 Sep. – Vol.46(6). – Р.307–314.

Fondy, T.P. Haloacetamido analogues of 2-amino-2-deoxy-D-mannose. Syntheses and effects on tumor-bearing mice / T.P. Fondy, C.A. Emlich // J. Med. Chem. – 1981. – Vol.24(7). – Р.848–52.

Food Standards Agency. Current EU approved additives and their E numbers. – 2016. [Accessed 19 October 2020]. – Электронный ресурс. – Доступ: https://www.food.gov.uk/science/additives/enumberlist#toc-4. – Дата обращения 24.12.2024 г.

Fujimoto, H. Production of beta-mannosyloligosaccharide / H. Fujimoto, K. Ajisaka // Pat. JPH089989, JP; applicant MEIJI MILK PROD CO LTD. – № JP19940173151; filing date: 04.07.1994; publication date: 16.01.1996.

Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection / H. Fukuda, T. Matsuzawa, Y. Abe [et al.] // Eur. J. Nucl. Med. – 1982. – Vol.7(7). – Р.294–297.

Fujisawa, T. Intestinal absorption of fructose in the rat / T. Fujisawa, J. Riby, N. Kretchmer // Gastroenterology. – 1991. – Vol.101(2). – Р.360–367.

In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET / S. Furumoto, R. Shinbo, R. Iwata [et al.] // J. Nucl. Med. – 2013. – Vol.54(8). – Р.1354–1361.

Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors / J. Gan, Y. Dou, Y. Li [et al.] // Biomaterials. – 2018. – Vol.178. – Р.95–108.

Gazi, U. Influence of the mannose receptor in host immuneresponses / U. Gazi, L. Martinez-Pomares // Immunobiology. – 2009. – Vol.214(7). – Р.554–561.

Gluud, L.L. Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis./ Gluud L.L., Vilstrup H., Morgan M.Y. // Hepatology. – 2016 Sep. – Vol.64(3). – Р.908–922.

Mannose impairs tumour growth and enhances chemotherapy / P.S. Gonzalez, J. O›Prey, S. Cardaci [et al.] // Nature. – 2018. – Vol.563(7733). – Р.719–723.

Grant, L.D. Physical and chemical stability of tagatose powder / L.D. Grant, L.N. Bell // J. Food Sci. – 2012 Mar. – Vol. 77(3). – Р.C308–313.

Grembecka, M. Sugar alcohols – their role in the modern world of sweeteners: a review / M. Grembecka // Eur. Food. Res. Tech. – 2015. – Vol.241. – Р.1–14.

Grembecka, M. Natural sweeteners in a human diet / M. Grembecka // Rocziniki Panstw. Zakl. Hig. – 2015. – Vol. 66. – Р.195–202.

Grenby, T.H. Latest state of research on lactitol and dental caries / T.H. Grenby // Int. Dent. J. – 1989 Mar. – №39(1). – Р.25–32.

Grenby, T.H. Dental and metabolic effects of lactitol in the diet of laboratory rats / T.H. Grenby, A. Phillips // Br. J. Nutr. – 1989 Jan. – Vol.61(1). – Р.17–24.

Grimble, G.K. Assimilation of lactitol, an unabsorbed disaccharide in the normal human colon / G.K. Grimble, D.H. Patil, D.B. Silk // Gut. – 1988. – Vol.29 (12). – Р.1666–1671.

D-mannose: a novel prognostic biomarker for patients with esophageal adenocarcinoma / J. Gu, D. Liang, J.A. Pierzynski [et al.] // Carcinogenesis. – 2017. – Vol.38(2). – Р.162–167.

Guan, Z.W. Soluble Dietary Fiber, One of the Most Important Nutrients for the Gut Microbiota / Z.W. Guan, E.Z. Yu, Q. Feng // Molecules. – 2021 Nov 11. – Vol. – 26(22). – Article 6802.

Guerrero-Wyss, M. D-Tagatose Is a Promising Sweetener to Control Glycaemia: A New Functional Food / M. Guerrero-Wyss, S. Dur?n Ag?ero, L. Angarita D?vila // Biomed. Res. Int. – 2018 Jan 9. – Vol. 2018. – Article 8718053.

Review article: The role of butyrate on colonic function. Aliment / H.M. Hamer, D. Jonkers, K. Venema [et al.] // Pharmacol. Ther. – 2008. – Vol.27. – Р.104–119.

Congenital disorder of glycosylation type 1b. Experience with mannose treatment / E.M. Hern?ndez, A.V. Pajares, B.P. Gonz?lez [et al.] // An Pediatr. (Barc). – 2008. – Vol.69. – №4. – P.358–365.

In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose / D.C. Hernot, T.W. Boileau, L.L. Bauer [et al.] // J. Agric. Food Chem. – 2009. – Vol.57. – Р.1354–1361.

Lactulose stimulates calcium absorption in postmenopausal women / E.G. van den Heuvel, T. Muijs, W. Van Dokkum, G. Schaafsma // J. Bone Miner. Res. – 1999. – Vol.14. – Р.1211–1216.

Holmes, D. Biomarkers: Mannose levels predict insulin resistance / D. Holmes // Nat Rev Endocrinol. – 2016. – Vol.12. – №9. – Article 2016.119.

Holst, J.J. The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism / J.J. Holst, C. Orskov // Diabetes. – 2004. – Vol.53 (suppl 3). – Р.197–204.

Propionate as a health-promoting microbial metabolite in the human gut / E. Hosseini, C. Grootaert, W. Verstraete, T. van de Wiele // Nutr Rev. – 2011 May. – Vol.69(5). – Р.245–258.

Hotta, N. New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition / N. Hotta // Nagoya Journal of Medical Science. 1997. – Т.60, Вып. 3–4. – С.89–100.

Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization / L. Huang, S. Biolsi, K.R. Bales, U. Kuchibhotla // Anal. Biochem. – 2006. –Vol.349. – №2. – P.197–207.

Hyams, J.S. Sorbitol intolerance: an unappreciated cause of functional gastrointestinal complaints / J.S. Hyams // Gastroenterology. – 1983 Jan. – Vol.84(1). – Р.30–33.

Inoue, S. Effect of L-arabinose on blood glucose level after ingestion of sucrose-containing food in human / S. Inoue, K. Sanai, K. Seri // J. Jpn. Soc. Nutr. Food Sci. – 2000. – Vol.53. – Р.243–247 (in Japanese).

Mutagenicity studies of lactitol (NS-4) / K. Iwakura, H. Tamura, M. Watanabe, N. Sumi // J. Toxicol. Sci. – 1994 Nov. – Vol.19, Suppl 3. – Р.487–497.

Jung, A. 10 Foods to Help Relieve Constipation / A. Jung // Diet & Nutrition. –2020, Aug 4. – Электронный ресурс. – Доступ: https://www.goodhousekeeping.com/health/diet-nutrition/g33492824/foods-that-relieve-constipation/. – Дата обращения 04.10.2024.

Anti-hyperglycemic effect of selected sugar alcohols (829.32) / Y.-R. Kang, S.-H. Jo, J.-I. Yoo [et al.] // Faseb J. – 2014. – Vol.28. – Р.829–832.

Kitler, M.E. Lactitol and lactulose. An in vitro and in vivo comparison of their effects on the human intestinal flora / M.E. Kitler // Drug Invest. – 1992. – Vol.4 (1). – Р.73–82.

Kneifel, W. In vitro growth behavior of probiotic bacteria in culture media with carbohydrates of prebiotic importance / W. Kneifel, A. Rajal and D. Kulbe // Microbial Ecology in Health and Disease. – 2000. – Vol.12. – Р.27–34.

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites / A. Koh, F. De Vadder, P. Kovatcheva-Datchary, F. B?ckhed // Cell. – 2016. – Vol.165. – Р.1332–1345.

Kondrashova, M.N. Polarographic observation of substrate-level phosphorylation and its stimulation by acetylcholine / M.N. Kondrashova, N.M. Doliba // FEBS Lett. – 1989. – Vol.243(2). – Р.153–155.

Prebiotic properties of mannose and its effect on specific resistance / O.S. Korneeva, I.V. Cheremushkina, A.S. Glushchenko [et al.] // Zh. Mikrobiol. Epidemiol. Immunobiol. – 2012. – №5. – Р.67–70.

Kranj?ec, B. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial / B. Kranj?ec, D. Pape?, S. Altarac // World J. Urol. – 2014. – Vol.32. – №1. – P.79–84.

The effects of L-arabinose on intestinal sucrase activity: dose-response studies in vitro and in humans / I. Krog-Mikkelsen, O. Hels, I. Tetens [et al.] // Am. J. Clin. Nutr. – 2011 Aug. – Vol.94(2). – Р.472–478.

L-Arabinose // National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 439195, L-Arabinose. – Электронный ресурс. – Доступ: https://pubchem.ncbi.nlm.nih.gov/compound/L-Arabinose. – Дата обращения 22.12.2024 г.

Lebek, G. Effect of lactulose and lactitol on human intestinal flora / G. Lebek, M. Luginb?hl // In: Hepatic encephalopathy. Management with lactulose and related carbohydrates / Editors: H.O. Conn and J. Bircher. – Michigan: Medi-Press, 1989. – P.245–266.

Mannose receptor-mediated regulation of serum glycoprotein homeostasis / D. ScevoLa, S.J. Lee, S. Evers [et al.] // Science. – 2002. – Vol. 295(5561). – Р.1898–1901.

Levin, G.V. Tagatose, the new GRAS sweetener and health product / G.V. Levin // J. of Med. Food. – 2002. – Vol.5(1). – Р.23–36.

Antiobesity effect of L-arabinose via ameliorating insulin resistance and modulating gut microbiota in obese mice / X. Li, Z. Cai, J. Liu [et al.] // Nutrition. – 2023 Jul. – Vol.111. – Article 112041.

Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure / T.P. Li, S.H. Guan, Q. Wang [et al.] // World J. Gastroenterol. – 2019. – Vol.25(37). – Р.5667–5675.

Liauw, S. Sorbitol: Often forgotten cause of osmotic diarrhea / S. Liauw, F. Saibil // Can. Fam. Physician. – 2019 Aug. – Vol.65(8). – Р.557–558.

Mannose receptor as a potential biomarker for gastric cancer: a pilot study / D.R. Liu, Q.L. Guan, M.T. Gao [et al.] // Int. J. Biol. Markers. – 2017. – Vol.32(3). – Р.278–283.

de Lonlay, P. The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib / P. de Lonlay, N. Seta // Biochim. Biophys. Acta. – 2009. – Vol.1792. – №9. – P.841–843.

L-Rhamnose // National Center for Biotechnology Information (2024). PubChem Compound LCSS for CID 25310. – Электронный ресурс. – Доступ: https://pubchem.ncbi.nlm.nih.gov/compound/L-Rhamnose#datasheet=LCSS. – Дата обращения 4.12.2024.

L-Rhamnose monohydrate // European Chemicals Agency (ECHA). – Электронный ресурс. – Доступ: https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/171856. – Дата обращения 04.10.2024.

L-Rhamnose Monohydrate for Intestinal Permeability // AOGU BIOTECH CO., LTD. – Электронный ресурс. – Доступ: https:// www.aogubio.com/ru/news/l-rhamnose-monohydrate-for-intestinal-permeability/. – Дата обращения 04.10.2024 г.

Lu, Y. Tagatose, a new antidiabetic and obesity control drug / Y. Lu, G.V. Levin, T.W. Donner // Diabetes Obes. Metab. – 2008 Feb. – Vol.10(2). – Р.109–134.

Luecke, K.J. Thermal stability of tagatose in solution / K.J. Luecke, L.N. Bell // Journal of Food Science. – 2010 May. – Vol. 75(4). – Р.346–351.

Maguire, A. Xylitol and caries prevention – is it a magic bullet? / A. Maguire, A.J. Rugg-Gunn // Br. Dent. J. – 2003 Apr 26. – Vol.194(8). – Р.429–436.

Proteome reference map of Lactobacillus acidophilus NCFM and quantitative proteomics towards understanding the prebiotic action of lactitol / A. Majumder, A. Sultan, R.R. Jersie-Christensen [et al.] // Proteomics. – 2011 Sep. – Vol.11(17). – Р.3470–3481.

Synbiotic effects of lactitol and Lactobacillus acidophilus NCFM in a semi-continuous colon fermentation model. / H. Makivuokko, S. Forssten, M. Saarinen [et al.]// Benef. Microbes. – 2010 Jun. – Vol. 1(2). – Р.131–137.

Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an eff ect of nonabsorbable disaccharides on small intestine ammonia generation / A. Masini, C. Efrati, M. Merli [et al.] // Am. J. Gastroenterol. – 1999 Nov. – Vol.94(11). – Р.3323–3327.

Matoori, S. Recent advances in the treatment of hyperammonemia / S. Matoori, J.C. Leroux // Adv. Drug. Deliv. Rev. – 2015 Aug 1. – Vol.90. – Р.55–68.

Maydeo, A. Lactitol or lactulose in the treatment of chronic constipation: result of a systematic / A. Maydeo // J. Indian Med. Assoc. – 2010 Nov. – Vol.108(11). – Р.789–792.

Effect of inulin-type fructans in patients undergoing cancer treatments: A systematic review / R. Mazraeh, F. Azizi-Soleiman, S.M.H.M. Jazayeri, S.M.A. Noori // Pak. J. Med. Sci. – 2019. – Vol.35(2). – Р.575–580.

N-glycosylation triggers a dual selection pressure in eukaryotic secretory proteins / M.L. Medus, G.E. Gomez, L.F. Zacchi [et al.] // Sci Rep. – 2017. – Vol.7(1). – Article 8788.

Miller, L.E. Efficacy and tolerance of lactitol supplementation for adult constipation: a systematic review and meta-analysis / L.E. Miller, J. Tennila, A.C. Ouwehand // Clin. Exp. Gastroenterol. – 2014 Jul 12. – Vol.7. – Р.241–248.

Moon, H. Biotechnological production of erythritol and its applications / H. Moon, M. Jeya, I. Kim, J. Lee // Appl. Microbiol. Biotechnol. – 2010. – Vol.86. – Р.1017–1025.

Mortensen, P.B. Short-chain fatty acid production from mono-and disaccharides in a fecal incubation system: Implications for colonic fermentation of dietary fiber in humans / P.B. Mortensen, K. Holtug, H.S. Rasmussen // J. Nutr. – 1988. – Vol.118. – Р.321–325.

Msomi, N.Z. Suitability of sugar alcohols as antidiabetic supplements: A review / N.Z. Msomi, O.L. Erukainure, M.S. Islam // J. Food Drug. Anal. – 2021, Mar 15. – Vol.29(1). – Р.1–14.

A Novel high-mannose specific lectin from the green alga hHalimeda renschii exhibits a potent anti-influenza virus activity through high-affinity binding to the viral hemagglutinin / J. Mu, M. Hirayama, Y. Sato [et al.] // Mar. Drugs 2017. – Vol.15(8). – Article E255.

Dietary prebiotics, milk fat globule membrane, and lactoferrin affects structural neurodevelopment in the young piglet / A.T. Mudd, L.S. Alexander, K. Berding [et al.] // Front. Pediatr. – 2016. – Vol. 4. – Article 4.

M?ller, J.B. Treatment of chronic portal-systemic encephalopathy with lactulose / J.B. M?ller, P. Guggenheim, U. Haemmerli // Lancet. – 1966. – Vol.287. – Р.890–893.

Single dose toxicity study of lactitol (NS-4) in dogs / R. Nagata, M. Onishi, K. Okasaki [et al.] // J. Toxicol. Sci. – 1994 Nov. – Vol.19 Suppl 3. – Р.301–304.

Carbohydrate-deficient glycoprotein syndrome type 1b. Phosphomannose isomerase deficiency and mannose therapy / R. Niehues, M. Hasilik, G. Alton [et al.] // J. Clin. Invest. – 1998. – Vol.101. – №7. – Р.1414–1420.

Reproductive and developmental toxicity studies of lactitol (NS-4) (4) – Perinatal and postnatal study in rats by oral administration / H. Ninomiya, K. Nishikawa, Y. Ide [et al.] // J. Toxicol. Sci. – 1994 Nov. – Vol.19. Suppl 3. – Р.471–485.

L-arabinose feeding prevents increases due to dietary sucrose in lipogenic enzymes and triacylglycerol levels in rats / S. Osaki, T. Kimura, T. Sugimoto [et al.] // J. Nutr. – 2001. – Vol.131. – Р.796–799.

Profiling Human Serum Antibodies with a Carbohydrate Antigen Microarray / O. Oyelaran, L.M. McShane, L. Dodd, J.C. Gildersleeve // J. Proteome. – 2009. – Vol.8(9). – Р.4301–4310.

Prevention of salmonella typhimurium colonization of broilers with d-mannose / B. Oyofo, J. DeLoach, D. Corrier [et al.] // Poult. Sci. – 1989. – Vol.68. – Р.1357–1360.

Treatment of porto-systemic encephalopathy with lactitolverus lactulose: a randomized controlled study / C.H. Pai, Y.S. Huang, W.C. Jeng [et al.] // Zhonghua Yi Xue Za Zhi (Taipei). – 1995 Jan. – Vol.55(1). – Р.31–36.

Papathanasopoulos, A. Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions / A. Papathanasopoulos, M. Camilleri // Gastroenterology. – 2010. – Vol.138. – Р.65–72.

A single and two step isomerization process for D-tagatose and L-ribose bioproduction using L-arabinose isomerase and D-lyxose isomerase / M.J. Patel, R.C. Akhani, A.T. Patel [et al.] // Enzyme and Microbial Technology. – 2017. – Vol.97. – Р.27–33.

Fructooligosaccharides and mannose affect Clostridium difficile adhesion and biofilm formation in a concentration-dependent manner / M. Piotrowski, D. Wulta?ska, P. Obuch-Woszczaty?ski, H. Pituch // Eur. J. Clin. Microbiol. Infect. Dis. – 2019. – Vol.38(10). – Р.1975–1984.

Tributyrin and lactitol synergistically enhanced the trophic status of the intestinal mucosa and reduced histamine levels in the gut of nursery pigs / A. Piva, A. Prandini, L. Fiorentini [et al.] // J. Anim Sci. – 2002 Mar. – Vol.80(3). – Р.670–680.

Effect of diets containing sucrose vs. D-tagatose in hypercholesterolemic mice / S.B. Police, J.C. Harris, R.A. Lodder, L.A. Cassis // Obesity. – 2009. – Vol.17(2). – Р.269–275.

Pontes, F.A. Colonic transit times and the effects of lactulose or lactitol in hospitalized patients / F.A. Pontes, A.T. Silva, A.Z. Cruz // European Journal of Gastroenterology and Hepatology. – 1995. – Vol.7. – Р.441–445.

Oral D-mannose in recurrent urinary tract infections in women: a pilot study / D. Porru, A. Parmigiani, C. Tinelli [et al.] // J. Clin. Urol. – 2014. – Vol.7(3). – Р.208–213.

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy / S. Prasad, R.K. Dhiman, A. Duseja [et al.] // Hepatology. – 2007. – Vol.45. – Р.549–559.

Inhibition by natural dietary substances of gastrointestinal absorption of starch and sucrose in rats and pigs: 1. Acute studies / H.G. Preuss, B. Echard, D. Bagchi, S. Stohs // Int. J. Med. Sci. – 2007. – Vol.4. – Р.196–202.

Inhibition by natural dietary substances of gastrointestinal absorption of starch and sucrose in rats 2. Subchronic studies / H.G. Preuss, B. Echard, D. Bagchi, S. Stohs // Int. J. Med. Sci. – 2007. – Vol.4. – Р.209–215.

Rhamnose // GSRS. – Электронный ресурс. – Доступ: https://gsrs.ncats.nih.gov/ginas/app/ui/substances/QN34XC755A. – Дата обращения 04.10.2024 г.

Serum mannose-binding lectin levels are linked with respiratory syncytial virus (RSV) disease / L.Z. Ribeiro, R.A. Tripp, L.M. Rossi [et al.] // J. Clin. Immunol. – 2008. – Vol.28(2). – Р.166–173.

Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients / O. Riggio, M. Varriale, G.P. Testore [et al.] // J. Clin. Gastroenterol. – 1990 Aug. – Vol.12(4). – Р.433–436.

Prebiotic concept and health / M. Roberfroid, G.R. Gibson, L. Hoyles [et al.] // British Journal of Nutrition. – 2010, August. – Vol. 104 Supplement No. S2. – Р.1–3.

Roelfmma, W.A. Chemical reception’s reactions of lactose derivatives / W.A. Roelfmma, B.F. Kuster // Netherlands Milk Dairy J. – 1998. – №42. – Р.469–483.

Rowe R.C., Sheskey P.J., Quinn M.E. (Eds.) // Handbook of Pharmaceutical Excipients; 6th edition. – London (England): Pharmaceutical Press. – 2009. – 680 p.

Effects of sweeteners on the gut microbiota: a review of experimental studies and clinical trials / F.J. Ruiz-Ojeda, J. Plaza-D?az, M.J. S?ez-Lara, A. Gil // Adv. Nutr. – 2019. – Vol.10. – Р.31–48.

Rushforth, K. Trees of Britain and Europe / K. Rushforth // Collins Wild Guide; Harpercollins Pub Ltd, 1999. – 1333 p.

Saarela, M. The effect of lactose derivatives lactulose, lactitol and lactobionic acid on the functional and technological properties of potentially probiotic Lactobacillus strains / M. Saarela, K. Hallamaa // International Dairy Journal. – 2003. – Vol.13. – P.291–302.

Functional food science and gastrointestinal physiology and function / S. Salminen, C. Bouley, M.C. Boutron-Ruault [et al.] // Br. J. Nutr. – 1998. – Vol.80, Suppl. 1. – Р.147–171.

Salminen, S. Lactic Acid Bacteria: Microbiology and Functional Aspects / S. Salminen, M.A. Deighton; ed. S. Salminen, A. von Wright. – New York, 1998. – P.211–231.

Lactic Acid Bacteria: Microbiology and Functional Aspects / S. Salminen, M. Robertroid [et al.]; ed. S. Salminen, A. von Wright. – New York, 1998. – P.343–358.

Intestinal bacterial toxins and alcohol liver damage: effects of lactitol, a synthetic disaccharide / D. Scevola, G. Bottari, L. Oberto [et al.] // La Clinica Dietologica. – 1993. – Vol.20(5). – Р.297–314.

Schutte, J.B. Nutritional implications and metabolizable energy value of D-xylose and L-arabinose in chicks / J.B. Schutte // Poult. Sci. – 1990. – Vol.69. – Р.1724–1730.

Schutte, J.B. Ileal digestibility and urinary excretion of D-xylose and L-arabinose in ileostomized adult roosters / J.B. Schutte, P. van Leeuwen, W.J. Lichtendonk // Poult. Sci. – 1991. – Vol.70. – Р.884–891.

Nutritional implications of L-arabinose in pigs / J.B. Schutte, J. de Jong, E.J. van Weerden, S. Tamminga // Br. J. Nutr. – 1992. – Vol.68. – Р.195–207.

L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals / K. Seri, K. Sanai, N. Matsuo [et al.] // Metabolism. – 1996. – Vol.45. – Р.1368–1374.

Sharma, V. Mannose metabolism: more than meets the eye / V. Sharma, M. Ichikawa, H.H. Freeze // Biochem. Biophys. Res. Commun. – 2014. – Vol.453. – №2. – P.220–228.

Effects of L-arabinose by hypoglycemic and modulating gut microbiome in a high-fat diet- and streptozotocin-induced mouse model of type 2 diabetes mellitus / D. Shen, Y. Lu, S. Tian [et al.] // J. Food Biochem. – 2021 Dec. – Vol.45(12). – e13991.

Shenderov, B.A. Metabiotics: novel idea or natural development of probiotic conception / B.A. Shenderov // Microb. Ecol. Health Dis. – 2013. – Vol. 24. – е20399.

Attenuated response of the serum triglyceride concentration to ingestion of a chocolate containing polydextrose and lactitol in place of sugar / Y. Shimomura, K. Maeda, M. Nagasaki [et al.] // Biosci. Biotechnol. Biochem. – 2005 Oct. – Vol.69(10). – Р.1819–1823.

Meta-analysis: The effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy / S. Shukla, A. Shukla, S. Mehboob, S. Guha // Aliment. Pharmacol. Ther. – 2011. –Vol.33. – Р.662–671.

Biocatalytic approaches using lactulose: end product compared with substrate / S.C. Silverio, E.A. Macedo, J.A. Teixeira [et al.] // Compr. Rev. – 2016. – Vol.15. – P.878–896.

Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis / J. Singh, A. Rivenson, M. Tomita [et al.] // Carcinogenesis. – 1997. – Vol.18(4). – Р.833–841.

Sorbitol // National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 5780, Sorbitol. – Электронный ресурс. – Доступ: https://pubchem.ncbi.nlm.nih.gov/compound/Sorbitol. – Дата обращения 27.12.2024 г.

Planting the seed: Origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota / L.F. Stinson, M.S. Payne, J.A. Keelan // Crit. Rev. Microbiol. – 2017. – Vol.43. – Р.352–369.

Discrimination of sepsis stage metabolic profi les with an LC/MS-MS-based metabolomics approach / L Su, Y. Huang, Y. Zhu [et al.] // BMJ Open Respir. Res. – 2014, Dec 10. – Vol. 1(1). – e000056.

Serum mannose-binding lectin concentration, but not genotype, is associated with Clostridium difficile infection recurrence: a prospective cohort study / A. Swale, F. Miyajima, R. Kolamunnage-Dona [et al.] // Clin. Infect. Dis. – 2014. – Vol.59(10). – Р.1429–1436.

Antidiabetic effect of D-tagatose in SHR/N-cp rats / B. Szepesi, G. Levin, L. Zehner, J. Saunders // The FASEB Journal. – 1996. – Vol.10. – Article 2659.

A mannosebindingreceptor is expressed on human keratinocytes and mediates killing of Candidaalbicans / G. Szolnoky, Z. Bata-Cs?rg?, A.S. Kenderessy [et al.] // J. Invest. Dermatol. – 2001. – Vol.117(2). – Р.205–213.

Tanaka, M. Method for producing degraded product of mannan / M. Tanaka, K. Oka // Pat. 2006034166, JP; applicant Miyarisan Pharma. – № JP20040218547; filing date: 27.07.2004; publication date: 09.02.2006.

Tanino, T. Suppression of natural cytotoxicity in tumor-bearing mice and inhibition of the suppression by D-mannose / T. Tanino, K. Egawa // Jpn. J. Exp. Med. – 1985. – Vol.55(4). – Р.155–160.

Taper, H.S. Inhibitory effect of dietary inulin or oligofructose on the development of cancer metastases / H.S. Taper, M.B. Roberfroid // Anticancer Res. – 2000. – Vol. 20(6B). – Р.4291–4294.

[Effects of lactitol on fecal bacterial flora in patients with liver cirrhosis and hepatic encephalopathy] / K. Tarao, S. Tamai, Y. Ito [et al.] // J. Jap. Soc. Gastroenterology (Nihon Shoka-kibyo Gakkai Zasshi). –1995 Jul. – 92(7). – Р.1037–1050.

Tarelli, E. Resistance to deglycosylation by ammonia of IgA1 Oglycopeptides: implications for the beta-elimination of O-glycans linked to serine and threonine / E. Tarelli // Carbohydr. Res. – 2007. – Vol. 342. – №15. – P. 2322-2325.

Te Morenga, L. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies / L. Te Morenga, S. Mallard, J. Mann // BMJ. – 2013. – Vol.346. – e7492.

Reproductive and developmental toxicity studies of lactitol (NS-4) (3) – Teratogenicity study in rabbits by oral administration / J.M. Tesh, F.W. Ross, T.J. Wightman [et al.] // J. Toxicol. Sci. – 1994 Nov. – Vol. 19 Suppl 3. – Р.463–470.

The Internet Drug Index for prescription drug information, interactions and side effects // RxList. – Электронный ресурс. – Доступ: https://www.rxlist.com/. – Дата обращения 30.09.2024 г.

Inulin-fortification of a processed meat product attenuates formation of nitroso compounds in the gut of healthy rats / R. Th?gersen, N. Gray, G. Kuhnle [et al.] // Food Chem. – 2020. – Vol.302. – е125339.

Timmermans, E. Whey: Proceedings of the 2nd Int›l Whey Conf. / E. Timmermans // Int›l Dairy Federation, Chicago, October 1997. – P.233–249.

Cooperative action of gut-microbiota-accessible carbohydrates improves host metabolic function / S. Tomioka, N. Seki, Y. Sugiura [et al.] // Cell. Rep. – 2022 Jul 19. – Vol.40(3). – е111087.

Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis / A. Trompette, E.S. Gollwitzer, K. Yadava [et al.] // Nat. Med. – 2014. – Vol.20. – Р.159–166.

US Patent No 20040151802, A23C 009/12. Process for manufacturing cheeses and other dairy products and products thereof / Kraft Foods R & D, Inc. Prior November 6, 2003. Рat. August 5, 2004.

US Patent No 10585524, A 23L 1/325. Meat based food product comprising lactobionic acid / Novozymes North America, Inc. Prior 07.07.2006. Publication 27.08.2009.

Innovative and fortified food: Probiotics, prebiotics, gmos, and superfood / T. Varzakas, P. Kandylis, D. Dimitrellou [et al.] // In: Preparation and Processing of Religious and Cultural Foods. – London, UK: Elsevier, 2018. – Р.67–129.

Towards microbial fermentation metabolites as markers for health benefits of prebiotics / K.A. Verbeke, A.R. Boobis, A. Chiodini [et al.] // Nutr. Res. Rev. – 2015. – Vol.28. – Р.42–66.

L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men / J.A. Vogt, K.B. Ishii-Schrade, P.B. Pencharz [et al.] // J. Nutr. – 2006. – Vol.136. – Р.2160–2166.

Detection of human IgM and IgG antibodies by means of galactofuranose-coated and rhamnose-coated gold nanoparticles / X. Wang, H. Chen, F. Chiodo, B. Tefsen // Matters. – 2019. – Электронный ресурс. – Доступ: https://researchinformation.amsterdamumc.org/en/publications/detection-of-human-igm-and-igg-antibodies-by-means-of-galactofura. Дата обращения 15.12.2024 г.

Effect of lactitol on intestinal bacteria / M. Watanabe, O. Takayuki, Y. Hirata [et al.] // Bifidus. – 1995. – Vol.9. – Р.19–26.

Weber, F., Jr. Lactulose and combination therapy of hepatic encephalopathy: The role of the intestinal microflora / F. Weber // Digest. Dis. – 1996. – Vol.14. – Р.53–63.

WHO. Guideline: Sugars intake for adults and children. Published 2015. [Электронный ресурс]. – Режим доступа: https://www.who.int/publications/i/item/9789241549028. Дата обращения 15.11.2024 г.

Sugar alcohols and diabetes: a review / T.M. Wolever, A. Piekarz, M. Hollands, K. Younker // Canad. J. Diabetes. – 2002. – Vol.26. – Р.356–362.

Effect of inulin-type fructans in patients undergoing cancer treatments: A systematic review. Structural characterization and anti-tumor effects of an inulin-type fructan from Atractylodes chinensis / J. Xu, D. Chen, C. Liu [et al.] // Int. J. Biol. Macromol. – 2016. – Vol.82. – Р.765–771.

Effects of lactitol-oligosaccharides on the intestinal microfl ora in rats / S. Yanahira, M. Morita, S. Aoe [et al.] // J. Nutr. Sci. Vitaminol (Tokyo). – 1995 Feb. – Vol.41(1). – Р.83–94.

Effects of lactitol-oligosaccharides on calcium and magnesium absorption in rats / S. Yanahira, M. Morita, S. Aoe [et al.] // J. Nutr. Sci. Vitaminol (Tokyo). – 1997 Feb. – Vol.43(1). – Р.123–132.

Preparation of selenium-enriched Bifidobacterium longum and its effect on tumor growth and immune function of tumor-bearing mice / Y. Yin, R.R. Wang, Y. Wang [et al.] // Asian Pac. J. Cancer. Prev. – 2014. – Vol.15(8). – Р.3681–3686.

Chicken mannose binding lectin has antiviral activity towards infectious bronchitis virus / W. Zhang, K.M. Bouwman, S.J. van Beurden [et al.] // Virology. – 2017. – Vol.509. – Р.252–259.

Effect of mannose on the lung function of rats with acute pancreatitis / W.F. Zhang, Z.T. Li, J.J. Fang [et al.] // J. Biol. Regul. Homeost. Agents. – 2018. – Р.32(3). – Р.627–633.

Starch structure modulates metabolic activity and gut microbiota profile / Z. Zhou, Y. Zhang, P. Zheng [et al.] // Anaerobe. – 2013. – Vol.24. – Р.71–78.